By Catherine Eckford2023-08-07T14:40:10
Continuous-flow manufacturing of the antibiotic cefazolin can cover mass production within compact manufacturing facilities and contribute to a stable drug supply, researchers have reported.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-22T14:48:00Z
Sponsored by CPhI
2026-05-21T08:24:00Z
2025-10-22T14:00:00
Sponsored by Bruker
2026-05-27T13:00:00 2026-05-27T14:00:00
Sponsored by TA Instruments
2025-07-25T08:10:00
Sponsored by JRS Pharma and Gattefosse, By European Pharmaceutical Review
2026-04-14T12:29:00
Sponsored by JRS Pharma, In association with Vetter Pharma
2025-06-03T13:35:00
Sponsored by bioMérieux, By European Pharmaceutical Review
Site powered by Webvision Cloud